Beyond Genomics Changes Name to BG Medicine, Pursues Drug-Development Applications | GenomeWeb

NEW YORK, Feb. 4 (GenomeWeb News) - Shifting its focus, Beyond Genomics has changed its name to BG Medicine and will now pursue the drug-development applications of its systems pharmacology platform, the company said yesterday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.